237 related articles for article (PubMed ID: 36928855)
1. Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics.
Carreon RL; Rivas-Grajales AM; Murphy N; Mathew SJ; Jha MK
Adv Neurobiol; 2023; 30():287-297. PubMed ID: 36928855
[TBL] [Abstract][Full Text] [Related]
2. Precision medicine for suicidality: from universality to subtypes and personalization.
Niculescu AB; Le-Niculescu H; Levey DF; Phalen PL; Dainton HL; Roseberry K; Niculescu EM; Niezer JO; Williams A; Graham DL; Jones TJ; Venugopal V; Ballew A; Yard M; Gelbart T; Kurian SM; Shekhar A; Schork NJ; Sandusky GE; Salomon DR
Mol Psychiatry; 2017 Sep; 22(9):1250-1273. PubMed ID: 28809398
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.
Le-Niculescu H; Roseberry K; Gill SS; Levey DF; Phalen PL; Mullen J; Williams A; Bhairo S; Voegtline T; Davis H; Shekhar A; Kurian SM; Niculescu AB
Mol Psychiatry; 2021 Jul; 26(7):2776-2804. PubMed ID: 33828235
[TBL] [Abstract][Full Text] [Related]
4. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
5. The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step method.
Rongen GA; Marquet P; van Gerven JMA;
Eur J Clin Pharmacol; 2021 May; 77(5):677-683. PubMed ID: 33210160
[TBL] [Abstract][Full Text] [Related]
6. New directions in psychiatric drug development: promising therapeutics in the pipeline.
Brady LS; Lisanby SH; Gordon JA
Expert Opin Drug Discov; 2023; 18(8):835-850. PubMed ID: 37352473
[TBL] [Abstract][Full Text] [Related]
7. Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.
Niciu MJ; Mathews DC; Nugent AC; Ionescu DF; Furey ML; Richards EM; Machado-Vieira R; Zarate CA
Depress Anxiety; 2014 Apr; 31(4):297-307. PubMed ID: 24353110
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-Guided Tailored Therapy.
Lydiard J; Nemeroff CB
Adv Exp Med Biol; 2019; 1192():199-224. PubMed ID: 31705496
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?
Salvadore G; Zarate CA
Biol Psychiatry; 2010 Nov; 68(9):780-2. PubMed ID: 20946973
[No Abstract] [Full Text] [Related]
10. Metabolomics Biomarkers for Precision Psychiatry.
Shih PB
Adv Exp Med Biol; 2019; 1161():101-113. PubMed ID: 31562625
[TBL] [Abstract][Full Text] [Related]
11. Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches.
Bauer S; van Alphen N; Becker A; Chiocchetti A; Deichmann R; Deller T; Freiman T; Freitag CM; Gehrig J; Hermsen AM; Jedlicka P; Kell C; Klein KM; Knake S; Kullmann DM; Liebner S; Norwood BA; Omigie D; Plate K; Reif A; Reif PS; Reiss Y; Roeper J; Ronellenfitsch MW; Schorge S; Schratt G; Schwarzacher SW; Steinbach JP; Strzelczyk A; Triesch J; Wagner M; Walker MC; von Wegner F; Rosenow F
Epilepsy Behav; 2017 Nov; 76():7-12. PubMed ID: 28917498
[TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
13. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.
Light GA; Swerdlow NR
Ann N Y Acad Sci; 2015 May; 1344(1):105-19. PubMed ID: 25752648
[TBL] [Abstract][Full Text] [Related]
14. The Translational Potential of Non-coding RNAs and Multimodal MRI Data Sets as Diagnostic and Differential Diagnostic Biomarkers for Mood Disorders.
Todeva-Radneva A; Aryutova K; Kandilarova S; Paunova R; Stoyanov D
Curr Top Med Chem; 2021; 21(11):949-963. PubMed ID: 34355686
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine in major depressive disorder -- opportunities and pitfalls.
Miller DB; O'Callaghan JP
Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040
[TBL] [Abstract][Full Text] [Related]
16. Personalized medicine: Prediction of disease vulnerability in mood disorders.
Prendes-Alvarez S; Nemeroff CB
Neurosci Lett; 2018 Mar; 669():10-13. PubMed ID: 27746310
[TBL] [Abstract][Full Text] [Related]
17. Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics.
Collins DC; Sundar R; Lim JSJ; Yap TA
Trends Pharmacol Sci; 2017 Jan; 38(1):25-40. PubMed ID: 27871777
[TBL] [Abstract][Full Text] [Related]
18. Precision psychiatry in clinical practice.
Zanardi R; Prestifilippo D; Fabbri C; Colombo C; Maron E; Serretti A
Int J Psychiatry Clin Pract; 2021 Mar; 25(1):19-27. PubMed ID: 32852246
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine Approaches to Mental Health Care.
Scala JJ; Ganz AB; Snyder MP
Physiology (Bethesda); 2023 Mar; 38(2):0. PubMed ID: 36099270
[TBL] [Abstract][Full Text] [Related]
20. Personalized translational epilepsy research - Novel approaches and future perspectives: Part I: Clinical and network analysis approaches.
Rosenow F; van Alphen N; Becker A; Chiocchetti A; Deichmann R; Deller T; Freiman T; Freitag CM; Gehrig J; Hermsen AM; Jedlicka P; Kell C; Klein KM; Knake S; Kullmann DM; Liebner S; Norwood BA; Omigie D; Plate K; Reif A; Reif PS; Reiss Y; Roeper J; Ronellenfitsch MW; Schorge S; Schratt G; Schwarzacher SW; Steinbach JP; Strzelczyk A; Triesch J; Wagner M; Walker MC; von Wegner F; Bauer S
Epilepsy Behav; 2017 Nov; 76():13-18. PubMed ID: 28917501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
